Business Standard
Home / India News / Marksans Pharma gets ANDA approval for Metformin Hydrochloride ER Tablets

Marksans Pharma gets ANDA approval for Metformin Hydrochloride ER Tablets

Image

Capital Market
Last Updated : May 03 2016 | 12:03 AM IST

From USFDA

Marksans Pharma announced that USFDA has granted approval for ANDA Metformin Hydrochloride Extended-Release (ER) Tablets USP 500mg and 750mg.

Powered by Capital Market - Live News

Also Read

Board of Marksans Pharma approves change in directorate

Board of Marksans Pharma approves change in directorate

Marksans Pharma standalone net profit rises 42.56% in the September 2015 quarter

Marksans Pharma standalone net profit rises 42.56% in the September 2015 quarter

Marksans Pharma consolidated net profit rises 11.91% in the September 2015 quarter

Marksans Pharma consolidated net profit rises 11.91% in the September 2015 quarter

Marksans Pharma to hold board meeting

Marksans Pharma to hold board meeting

Marksans Pharma to hold board meeting

Marksans Pharma to hold board meeting

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 02 2016 | 2:31 PM IST

Explore News

Market LIVEMarket TodaySai Life Sciences IPOParliament Winter Session 2024 LIVELatest News LIVEStocks To Watch TodayProcess to withdraw PF by ATMGold-Silver Price TodayIPO NewsBusiness Standard at 50
HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2024 Business Standard Private Ltd. All rights reserved
LinkedIN Icon